Although interferons (IFNs) such as IFNγ increase acute myocarditis, they might also be of protective value, as they decrease viral replication and protect against chronic inflammatory cardiomyopathy by inhibiting profibrotic factors including IL-4 and IL-17 (21, 41, 44–47). Here, IL4 is linked to myocarditis.